The US Agency for International Development (USAID), the American National Standards Institute (ANSI), and Advanced Medical Technology Association (AdvaMed) is hosting a Workshop on Good Regulatory Practices and its implementation in the Medical Device Sector on 31 January and 01 February 2023. To register, click here. Read...
Many of you have heard about this strange sounding medication, Cabotegravir (Cah-bot-er-grah-ver), floating around news broadcasts and print outlets. Well, this medication is a Human Immunodeficiency Virus (HIV) anti-retroviral (ARV) that has been recently approved by the South African Health Products Regulatory Authority (SAHPRA). What is...
Pretoria, 2 December 2022 – The South African Health Products Regulatory Authority (SAHPRA) has registered Cabotegravir (Apretude 600 mg/3ml injection), a long-acting HIV pre-exposure prophylactic. Cabotegravir is an antiretroviral drug (ARV) that people living with HIV may use, together with other ARVs, to keep the virus...
Pretoria, 2 December 2022 – With the establishment of the South African Health Products Regulatory Authority (SAHPRA) in February 2018, the regulatory authority inherited a backlog of approximately 16 000 new product and variation applications from its predecessor, the Medicines Control Council (MCC). As is generally...
Pretoria, 24 November 2022 – In the past year, the South African Health Products Regulatory Authority (SAHPRA) approved the antigen test kits for use by healthcare professionals. SAHPRA has now approved seven (7) COVID-19 antigen self-test kits that can be used as self-test/ at home tests...
Pretoria, 23 November 2022 – On 6 April 2021, the Pretoria High Court issued a consent court order pertaining to four cases that were brought against the South African Health Products Regulatory Authority (SAHPRA) and the Minister of Health regarding access to Ivermectin for use...
22 November 2022 Embargo: Immediate release Pretoria, 22 November 2022 - The South African Health Products Regulatory Authority (SAHPRA) has registered Pfizer’s COMIRNATY Ready To Use (RTU) ADULT VACCINE and Dilute To Use (DTU) PAEDIATRIC VACCINE on 15 November 2022. The RTU vaccine, as the name...
Pretoria, 21 November 2022 – As a rebellious teenager growing up in the British town of Harpenden, Helen Rees would sneak out to attend anti-apartheid talks. “That was the stop-the-Boks tour,” she recalls. “[British politician] Peter Hain was an activist trying to stop the Springboks...
Pretoria, 4 November 2022 – The South African Health Products Regulatory Authority (SAHPRA) received an accolade from the National Press Club (NPC) on 3 November 2022 at a gala dinner event. “As was the case for many other organisations, the COVID-19 pandemic restricted the National Press...
Pretoria, 4 November 2022 – The South African Health Products Regulatory Authority (SAHPRA) takes note of the alleged procurement of hospital consumables and medical devices in breach of the Medicines and Related Substances Act (Act 101 of 1965, as amended). SAHPRA is currently investigating the matter....
